• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肝癌手术

Surgery for small liver cancers.

作者信息

Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S

机构信息

First Department of Surgery, Shinshu University, School of Medicine, Japan.

出版信息

Semin Surg Oncol. 1993 Jul-Aug;9(4):298-304. doi: 10.1002/ssu.2980090404.

DOI:10.1002/ssu.2980090404
PMID:8210909
Abstract

During the last 16 years, we have resected small hepatocellular carcinomas (HCCs) measuring 5 cm or less from 362 patients, 266 of whom also had liver cirrhosis. The operative and hospital mortality rate were 1.7% and 1.9%, respectively. These showed a gradual decrease year by year in parallel with reduction of intraoperative blood loss achieved by the selective vascular occlusion technique and Pringle method. In 1989, 87% of hepatectomy patients were discharged without the need for whole blood transfusion, and 5-year survival was 43.7%. Tumor size, number of tumors, intrahepatic metastasis, vascular invasion, and capsular invasion were significant prognostic factors. Edmondson grade and the operative procedure employed were significantly related to outcome. Our standard policy for selection of operative procedures and perioperative care is described, and the selection of treatment modalities is discussed.

摘要

在过去16年里,我们对362例患者的直径5厘米及以下的小肝细胞癌(HCC)进行了切除,其中266例患者还患有肝硬化。手术死亡率和医院死亡率分别为1.7%和1.9%。随着选择性血管阻断技术和普林格尔法使术中失血量减少,这些死亡率逐年逐渐下降。1989年,87%的肝切除患者出院时无需输注全血,5年生存率为43.7%。肿瘤大小、肿瘤数量、肝内转移、血管侵犯和包膜侵犯是重要的预后因素。埃德蒙森分级和所采用的手术操作与预后显著相关。本文描述了我们选择手术操作和围手术期护理的标准策略,并讨论了治疗方式的选择。

相似文献

1
Surgery for small liver cancers.小肝癌手术
Semin Surg Oncol. 1993 Jul-Aug;9(4):298-304. doi: 10.1002/ssu.2980090404.
2
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.伴有肝硬化的肝细胞癌行肝大部切除术后的医院死亡率
Arch Surg. 1995 Feb;130(2):198-203. doi: 10.1001/archsurg.1995.01430020088017.
3
Surgical therapy of hepatocellular carcinoma in the cirrhotic liver.肝硬化肝脏中肝细胞癌的外科治疗
Swiss Surg. 1999;5(3):107-10. doi: 10.1024/1023-9332.5.3.107.
4
[Surgical treatment of small hepatocellular carcinoma].[小肝癌的外科治疗]
Gan To Kagaku Ryoho. 1996 Jun;23(7):849-54.
5
A prospective randomized controlled trial to compare pringle manoeuvre with hemi-hepatic vascular inflow occlusion in liver resection for hepatocellular carcinoma with cirrhosis.一项前瞻性随机对照临床试验比较了在伴有肝硬化的肝细胞癌肝切除术中普雷灵手法与半肝入肝血流阻断的效果。
J Gastrointest Surg. 2013 Aug;17(8):1414-21. doi: 10.1007/s11605-013-2236-z. Epub 2013 May 29.
6
Microwave surgery in the treatment of hepatocellular carcinoma.微波手术治疗肝细胞癌
Semin Surg Oncol. 1993 Jul-Aug;9(4):318-22. doi: 10.1002/ssu.2980090407.
7
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
8
Surgical treatment of hepatocellular carcinoma.肝细胞癌的外科治疗
Cancer Chemother Pharmacol. 1994;33 Suppl:S12-7. doi: 10.1007/BF00686661.
9
[Surgical treatment of primary liver cancer complicated with cirrhosis].
Zhonghua Zhong Liu Za Zhi. 1992 Mar;14(2):147-9.
10
The Japanese approach to surgical treatment of hepatocellular carcinoma in liver cirrhosis: impressions of an Italian FPCR fellow.日本对肝硬化患者肝细胞癌的手术治疗方法:一位意大利FPCR研究员的印象
Jpn J Clin Oncol. 1997 Aug;27(4):289-91. doi: 10.1093/jjco/27.4.289.

引用本文的文献

1
FIB-3 index as a novel age-independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy.FIB-3指数作为肝切除术后肝细胞癌患者肝纤维化及预后的新型年龄无关预测指标。
Ann Gastroenterol Surg. 2025 Apr 13;9(5):1055-1065. doi: 10.1002/ags3.70010. eCollection 2025 Sep.
2
Radiomics Beyond Radiology: Literature Review on Prediction of Future Liver Remnant Volume and Function Before Hepatic Surgery.放射组学超越放射学:肝脏手术前预测未来肝剩余体积和功能的文献综述
J Clin Med. 2025 Jul 28;14(15):5326. doi: 10.3390/jcm14155326.
3
Risk for Recurrence After Liver Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Detected After Sustained Virological Response by Direct-Acting Antivirals: A Retrospective Multicenter Study.
直接抗病毒药物实现持续病毒学应答后检测出的丙型肝炎病毒相关性肝细胞癌患者肝切除术后的复发风险:一项回顾性多中心研究
Cancers (Basel). 2025 Jun 11;17(12):1946. doi: 10.3390/cancers17121946.
4
Predicting post-hepatectomy liver failure based on future remnant liver function combined with future remnant liver volume using magnetic resonance imaging.基于磁共振成像,利用未来残余肝功能联合未来残余肝体积预测肝切除术后肝衰竭
Langenbecks Arch Surg. 2025 Jun 6;410(1):177. doi: 10.1007/s00423-025-03764-y.
5
Optimizing Treatment Selection for Early Hepatocellular Carcinoma Based on Tumor Biology, Liver Function, and Patient Status.基于肿瘤生物学、肝功能和患者状况优化早期肝细胞癌的治疗选择
J Hepatocell Carcinoma. 2025 Apr 16;12:777-790. doi: 10.2147/JHC.S514248. eCollection 2025.
6
Comparison of the surgical difficulty between segment 7 and 8 partial liver resection untilizing the laparoscopic and open approaches.利用腹腔镜和开放手术入路比较肝Ⅶ段和Ⅷ段部分肝切除术的手术难度
Surg Today. 2025 Apr 9. doi: 10.1007/s00595-025-03037-7.
7
Appropriate methods of evaluating future liver remnant volume to predict postoperative liver failure after major hepatectomy based on the body mass of patients with normal hepatic reserve.基于肝储备正常患者的体重,评估未来肝残余体积以预测大肝切除术后肝衰竭的合适方法。
Surg Today. 2025 Mar 27. doi: 10.1007/s00595-025-03030-0.
8
Liver function estimation using multiphase hepatic CT: diagnostic performance of iodine-uptake and volumetric parameters.使用多期肝脏CT评估肝功能:碘摄取和容积参数的诊断性能
Eur Radiol. 2025 Mar 13. doi: 10.1007/s00330-025-11497-1.
9
Third Liver Resection for Re-recurrent Hepatocellular Carcinoma: Assessment of the Prognostic Factors of Long-term Survival.复发性肝细胞癌第三次肝切除:长期生存预后因素评估
Cancer Diagn Progn. 2025 Mar 3;5(2):162-170. doi: 10.21873/cdp.10426. eCollection 2025 Mar-Apr.
10
Surgical treatment for hepatocellular carcinoma in era of multidisciplinary strategies.多学科策略时代的肝细胞癌外科治疗
Int J Clin Oncol. 2025 Mar;30(3):417-426. doi: 10.1007/s10147-025-02703-7. Epub 2025 Feb 5.